Ciprofloxacin
Product Images NDC 67296-0608

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 67296-0608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Copy Of Label (6729606083)

Label for Ciprofloxacin 250 mg tablets, containing 14 tablets per package. The label includes the NDC 67296-0608-3 and indicates the product is Rx only. Manufactured by Cobalt Pharmaceuticals Inc., Mississauga, Canada, and distributed by Redpharm Drug Inc., Eden Prairie, MN. Storage instructions specify controlled room temperature (20-25°C).*

FDA Label Image

Cipro-structure01.jpg (Cipro Structure01)

Chemical structure diagram of Ciprofloxacin showing the molecular arrangement including fluorine, carboxylic acid (COOH), and other functional groups typical for this antibacterial agent.*

FDA Label Image

Cipro-structure02.jpg (Cipro Structure02)

Chemical structure of Ciprofloxacin showing its molecular arrangement including a piperazine ring, fluorine atom, carboxylic acid group, and cyclopropyl moiety as part of its quinolone core structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.